Di Bidino Rossella, Lipska Iga, Kukla Monika, von Pinoci Marina, Papavero Sara Consilia, Marchetti Marco, Sampietro-Colom Laura, Cicchetti Americo
Graduate School of Health Economics and Management, Università Cattolica del Sacro Cuore (ALTEMS), Rome, Italy.
Department of Health Technologies and Innovation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Int J Technol Assess Health Care. 2025 Mar 18;41(1):e19. doi: 10.1017/S0266462325000108.
Hospital-Based Health Technology Assessment (HB-HTA) is a heterogeneous phenomenon constantly evolving to respond to the needs of decision-makers at the hospital level. In 2023, The HB-HTA Interest Group of Health Technology Assessment International (HTAi) surveyed HB-HTA activities with the aim to provide an updated description of the actual scenario.
An online survey was conducted to gather data on the main characteristics of hospitals, HB-HTA activities, outputs, role in the decision-making processes, dissemination and training activities, and their interaction and collaboration with other stakeholders and HTA-related regulations. Finally, the survey collected feedback on the perception of and current barriers to HB-HTA. Three categories of responders were identified: Both hospitals performing and not performing HTA and policymakers.
Eighty-seven responses were collected from twenty-eight countries. Nearly half of the responders ( = 41) conducted HB-HTA, whereas eighteen consisted of hospitals not performing HTA, and twenty-eight were policy makers. HB-HTA was performed mainly in hospitals with >500 beds. HB-HTA units were organized in 40 percent of cases as an "independent group." The survey showed that HTA units could contribute to all the steps of the decision-making processes, whereas the impact of the assessments on the decisions was mainly perceived as a medium. Furthermore, HB-HTA was not seen as a duplication of effort, even without specific regulations.
The survey highlighted the role of HB-HTA in hospital decision-making supporting the vision of HB-HTA as one of the actors in the HTA ecosystem, the success of which depends on collaboration with other stakeholders.
基于医院的卫生技术评估(HB-HTA)是一种不断演变的异质现象,旨在满足医院层面决策者的需求。2023年,国际卫生技术评估协会(HTAi)的HB-HTA兴趣小组对HB-HTA活动进行了调查,旨在提供对实际情况的最新描述。
开展了一项在线调查,以收集有关医院的主要特征、HB-HTA活动、产出、在决策过程中的作用、传播和培训活动,以及它们与其他利益相关者的互动与合作和HTA相关法规的数据。最后,该调查收集了关于对HB-HTA的认知和当前障碍的反馈。确定了三类受访者:进行和未进行HTA的医院以及政策制定者。
从28个国家收集到87份回复。近一半的受访者(n = 41)开展了HB-HTA,其中18份来自未进行HTA的医院,28份来自政策制定者。HB-HTA主要在床位超过500张的医院进行。40%的情况下,HB-HTA单位被组织为一个“独立小组”。调查显示,HTA单位可以为决策过程的所有步骤做出贡献,而评估对决策的影响主要被认为是中等程度。此外,即使没有具体法规,HB-HTA也不被视为重复工作。
该调查突出了HB-HTA在医院决策中的作用,支持将HB-HTA视为HTA生态系统中的参与者之一的观点,其成功取决于与其他利益相关者的合作。